Communication, documentation key in COVID litigation defense, legal experts say
By
Kimberly Bonvissuto
Oct 28, 2022
COVID-19 continues to challenge senior living and other long-term care providers on various levels. But the message from the legal field remains consistent: communicate and document.
Long COVID development influenced by older age, gender, but vaccination can counter risk
By
Kimberly Bonvissuto
Oct 28, 2022
Long COVID is prevalent among older adults and women, but the risk of developing persistent COVID-19 symptoms can be lowered through vaccination, according to a new study published Thursday in JAMA Network...
Flu, COVID-19 vaccination cover high among healthcare personnel
Oct 24, 2022
The lowest influenza, COVID-19 primary series, and COVID-19 booster dose vaccination coverage was seen among assistants and aides, those working in long-term care or home health care settings, and those...
FDA OKs Novavax COVID-19 vaccine as first booster shot
Oct 20, 2022
Until now, the protein-based vaccine was only approved as a two-dose primary series.
States ending COVID-related pandemic emergency measures
By
Kimberly Bonvissuto
Oct 19, 2022
Although COVID-19 isn’t quite in the rear view mirror, especially for senior living and other long-term care providers, some states are dropping pandemic-related restrictions that affect providers.
70 percent of COVID deaths are among those 75+, experts say, urging staying up to date on vaccination
By
Kimberly Bonvissuto
Oct 11, 2022
Despite many Americans being determined to “move on” from the pandemic and resume normal activities, COVID-19 continues to exact a toll, particularly among older adults, according to two new data analyses.
Affordable senior housing providers say they are stretched thin due to a host of operational and workforce challenges, but partnerships with outside agencies are helping them meet residents’ needs, according...
COVID-19 boosters could save 90,000 lives this winter
Oct 06, 2022
Updated booster doses also could prevent more than 936,000 hospitalizations and save $56 billion in six months.
Bivalent mRNA-1273.214 elicits better response against omicron
Sep 27, 2022
A booster dose of mRNA-1273.214 elicits more neutralizing antibodies against omicron compared with mRNA-1273, the original Moderna vaccine, with no new safety concerns.
More news for Tuesday, Sept. 13
By
Kimberly Bonvissuto
Sep 13, 2022
Senate Aging Committee members seek information on alleged Alzheimer’s research fraud … 14 state governors launch healthcare workforce collaborative … CMS: Free updated COVID-19 vaccines provide...